Myofibrosarcoma of the upper jawbones: a clinicopathologic and ultrastructural study of two cases.
Two problematic spindle cell sarcomas involving upper jawbones in two adult male patients have been studied by histology, immunohistochemistry, and transmission electron microscopy, and respectively graded as low-grade malignancy and high-grade malignancy. While any single methodological study did not allow confident classification of them into one or other of the classical categories of spindle cell sarcomas (fibrosarcoma versus leiomyosarcoma), the overall contribution from all three methodologies ultimately allowed them to be categorized as sarcomas with myofibroblastic differentiation. Histologically, both tumors had morphological features of an amalgama between neoplastic fibroblasts and smooth muscle cells. Immunohistochemically, both tumors expressed reactivity only for muscle specific actin and alpha smooth muscle actin, in addition to vimentin. Ultrastructurally, both tumors, while showing fibroblast-like cytoplasmic features, had a spurious and imperfectly organized cell surface defying convincing classification into any of specific categories (i.e., both appeared in terms of ultrastructure as poorly differentiated sarcoma, the former with low level of smooth muscle differentiation and possibly the presence of some fibronexus component, the latter with no smooth muscle differentiation but with possible evidence of very rare fibronectin fibril). Therefore, on balance, the most tenable diagnosis seemed to us that of a myofibrosarcoma in both cases. This work is presented considering the fact that myofibrosarcoma currently represents a topical theme of debate, and that this is the first report in medical literature concerning with myofibrosarcomas of the head and neck area in adults.
Bisceglia
M
M
Servizio di Anatomia Patologica, IRCCS-Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. bismi@libero.it
Tricarico
N
N
Minenna
P
P
Magro
G
G
Pasquinelli
G
G
D000199:Actins / Q000032:analysis; D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D003593:Cytoplasm / Q000648:ultrastructure; D017809:Fatal Outcome; D005347:Fibroblasts / Q000648:ultrastructure; D005354:Fibrosarcoma / Q000737:chemistry / Q000628:therapy / Q000648:ultrastructure*; D006801:Humans; D007124:Immunoenzyme Techniques; D007890:Leiomyosarcoma / Q000737:chemistry / Q000628:therapy / Q000648:ultrastructure*; D008297:Male; D008441:Maxillary Neoplasms / Q000737:chemistry / Q000628:therapy / Q000648:ultrastructure*; D008875:Middle Aged; D014057:Tomography, X-Ray Computed; D014746:Vimentin / Q000032:analysis
D000199:Actins; D014408:Biomarkers, Tumor; D014746:Vimentin